KalVista Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $54,278,000.
Profit Margin
| 2015 | 1.80M | -7.22M | -400.55% |
|---|---|---|---|
| 2016 | 2.13M | -11.43M | -536.15% |
| 2017 | 1.50M | -18.60M | -1236.9% |
| 2018 | 8.39M | -15.80M | -188.29% |
| 2019 | 16.12M | -20.81M | -129.08% |
| 2020 | 12.69M | -29.11M | -229.44% |
| 2021 | 12.69M | -44.49M | -350.62% |
| 2022 | 0 | -68.51M | |
| 2023 | 0 | -74.85M | |
| 2024 | 0 | -126.64M |
KALV Income Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 12.69M | 12.69M | 16.12M | 8.39M | 1.50M | 2.13M | 1.80M |
Cost of revenue | 86.16M | 802K | 743K | 651K | 40.19K | 35.02K | 18.23K | 12.66K | 14.66K | 8.28K |
Gross profit | -86.16M | -802K | -743K | 12.03M | 12.64M | 16.09M | 8.37M | 1.49M | 2.11M | 1.79M |
Operating exp. | ||||||||||
Research and development | 86.16M | 80.27M | 70.16M | 41.28M | 40.19M | 35.02M | 18.23M | 12.66M | 14.66M | 8.28M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 54.27M | 110.87M | 96.61M | 57.92M | 53.22M | 45.94M | 27.09M | 23.84M | 17.31M | 9.89M |
Operating income | -140.44M | -110.87M | -96.61M | -57.92M | -40.53M | -29.82M | -18.70M | -22.33M | -15.18M | -8.08M |
Other income (expenses), net | 5.34M | 17.96M | 14.27M | 11.67M | 11.29M | 7.73M | 2.81M | 3.73M | 3.69M | 863K |
Income before tax | -135.09M | -92.90M | -82.33M | -46.24M | -29.24M | -20.69M | -15.80M | -18.60M | -11.43M | -7.22M |
Income tax expense | -8.45M | -18.05M | -13.82M | -1.75M | -124K | 124K | -1.32M | -5.10M | -5.40M | -863K |
Net income | -126.64M | -74.85M | -68.51M | -44.49M | -29.11M | -20.81M | -15.80M | -18.60M | -11.43M | -7.22M |
Earnings per share | ||||||||||
Basic EPS | -3.44 | -2.68 | -2.8 | -2.33 | -1.64 | -1.38 | -1.53 | -1.92 | -19.34 | -6.17 |
Diluted EPS | -3.44 | -2.68 | -2.8 | -2.33 | -1.64 | -1.38 | -1.53 | -1.92 | -19.34 | -6.17 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |